Richard W. Martin - Concepedia

Author

Richard W. Martin

Also Known As

Martin, R, R Martin, R W Martin, R. Martin, R. W. Martin, R.W. Martin, RICHARD W. MARTIN, Richard Martin, Richard W Martin, Richard W. Martin

116

Publications

8.6K

Citations

H-Index

Concepts

All Affiliations

Michigan State University Grand Rapids Community College Johns Hopkins University University of Alabama at Birmingham University of California, Los Angeles

About

Richard W. Martin is an author at Michigan State University specializing in medicine, social sciences, and sociology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	769
2	Business	4	4	148
3	Engineering	3	3	142
4	Language Studies	1	1	15
5	Law	1	1	14

Richard W. Martin

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis Joan M. Bathon, Richard W. Martin, Roy Fleischmann, New England Journal of Medicine	2000	1.8K
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. Philip J. Clements, Peter A. Lachenbruch, Jill Siebold, PubMed	1995	876
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes Mark C. Genovese, Joan M. Bathon, Richard W. Martin, Arthritis & Rheumatism	2002	731
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, The Lancet Respiratory Medicine Autoimmune DiseaseSystemic SclerodermaImmunologySystemic SclerosisMultiple Sclerosis	2020	612
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial Philip J. Clements, Daniel E. Fürst, Weng Kee Wong, Arthritis & Rheumatism	1999	330
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon Peter A. Merkel, Karen Herlyn, Richard W. Martin, Arthritis & Rheumatism	2002	326
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial Philip J. Clements, Eric L. Hurwitz, Weng Kee Wong, Arthritis & Rheumatism	2000	282
Predictors and outcomes of scleroderma renal crisis: The high‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis trial Paul J. DeMarco, Michael H. Weisman, James R. Seibold, Arthritis & Rheumatism	2002	223
Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. Larry W. Moreland, S. Cohen, Scott W. Baumgartner, PubMed	2001	201
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study Fredrick M. Wigley, Joseph H. Korn, Mary Ellen Csuka, Arthritis & Rheumatism	1998	196

Page 1